Rahul Srinivasan, Chief Financial Officer, said “This record-breaking quarter stands as a testament to the passion and commitment of our entire team at Grifols (GRFS) towards our mission of improving patients’ lives globally and supporting our donors. We remain firmly focused on our ongoing priorities of deleveraging and free cash flow generation.”
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GRFS:
- Brookfield awaiting information for potential Grifols bid, Bloomberg says
- Brookfield still pursuing Grifols deal, Bloomberg reports
- Grifols SA (GRFS) Q3 Earnings Cheat Sheet
- Grifols price target lowered to EUR 15.50 from EUR 15.60 at Berenberg
- Grifols receives FDA approval to treat surgical bleeding with FS solution